These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10420387

  • 1. Effects of saiboku-to on the survival of human eosinophils.
    Tohda Y, Haraguchi R, Kubo H, Muraki M, Fukuoka M, Nakajima S.
    Methods Find Exp Clin Pharmacol; 1999 Jun; 21(5):327-30. PubMed ID: 10420387
    [Abstract] [Full Text] [Related]

  • 2. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S, Tadokoro K, Ito K, Nakagawa T.
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [Abstract] [Full Text] [Related]

  • 3. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M.
    Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651
    [Abstract] [Full Text] [Related]

  • 4. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: comparison with airway eosinophils.
    Sedgwick JB, Quan SF, Calhoun WJ, Busse WW.
    J Allergy Clin Immunol; 1995 Sep 15; 96(3):375-85. PubMed ID: 7560640
    [Abstract] [Full Text] [Related]

  • 5. Blood eosinophil leukotriene C4 production in asthma of different severities.
    Laviolette M, Ferland C, Comtois JF, Champagne K, Bossé M, Boulet LP.
    Eur Respir J; 1995 Sep 15; 8(9):1465-72. PubMed ID: 8575570
    [Abstract] [Full Text] [Related]

  • 6. Taurine chloramine inhibits functional responses of human eosinophils in vitro.
    Martinez-Losa M, Cortijo J, Piqueras L, Sanz MJ, Morcillo EJ.
    Clin Exp Allergy; 2009 Apr 15; 39(4):537-46. PubMed ID: 19222497
    [Abstract] [Full Text] [Related]

  • 7. Cytokines directly induce degranulation and superoxide production from human eosinophils.
    Horie S, Gleich GJ, Kita H.
    J Allergy Clin Immunol; 1996 Aug 15; 98(2):371-81. PubMed ID: 8757214
    [Abstract] [Full Text] [Related]

  • 8. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
    Sarmiento EU, Espiritu BR, Gleich GJ, Thomas LL.
    J Immunol; 1995 Aug 15; 155(4):2211-21. PubMed ID: 7543541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
    Gruart V, Truong MJ, Plumas J, Zandecki M, Kusnierz JP, Prin L, Vinatier D, Capron A, Capron M.
    Blood; 1992 May 15; 79(10):2592-7. PubMed ID: 1375105
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.
    Her E, Frazer J, Austen KF, Owen WF.
    J Clin Invest; 1991 Dec 15; 88(6):1982-7. PubMed ID: 1752957
    [Abstract] [Full Text] [Related]

  • 13. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro.
    Zhang S, Mohammed Q, Burbidge A, Morland CM, Roche WR.
    Eur Respir J; 1996 Sep 15; 9(9):1839-46. PubMed ID: 8880100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14.
    Paul CC, Ackerman SJ, Mahrer S, Tolbert M, Dvorak AM, Baumann MA.
    J Leukoc Biol; 1994 Jul 15; 56(1):74-9. PubMed ID: 8027673
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3.
    Blom M, Tool AT, Kok PT, Koenderman L, Roos D, Verhoeven AJ.
    Blood; 1994 May 15; 83(10):2978-84. PubMed ID: 8180394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eosinophil apoptosis as a therapeutic target in allergic asthma.
    Ilmarinen P, Kankaanranta H.
    Basic Clin Pharmacol Toxicol; 2014 Jan 15; 114(1):109-17. PubMed ID: 24148899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.